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Objectives: to assess nurses’ perceptions of risk factors for the development of phlebitis, with a 
special focus on the perception of phlebitic potentials of some infusion medications and solutions. 
Method: a cross-sectional questionnaire study, which included a sample of 102 nurses. Results: 
Nurses recognized some factors that may reduce the incidence of phlebitis; however, more 
than half of the nurses were unaware that the material and diameter of the cannula can affect 
the incidence rate of phlebitis. Furthermore,underlying disease and high pH of medications or 
solutions were identified as potential risk factors, whereas low pH and low osmolality were not. 
Nurses identified Vancomycin and Benzylpenicillin antibiotics with the strongest phlebitic potential. 
Among other medications and intravenous fluids, Aminophylline, Amiodaronehydrochloride and 
Potassium chloride 7.4% were identified as potentially causing phlebitis. Conclusion: predisposing 
factors for phlebitis relating to patients and administered therapy were identified by nurses, 
while some cannula related risk factors, in particular its physicochemical properties and the time 
for cannula replacement, were not fully perceived.







Rev. Latino-Am. Enfermagem 2015 July-Aug.;23(4):677-84.
Introduction
Phlebitis (mechanical, chemical and bacterial) is 
a common local complication of peripheral intravenous 
therapy administered through a peripheral venous 
cannula(1). According to the standards of the Infusion 
Nurses Society (INS), the accepted phlebitis rate is 
5% or less(2). However, research findings suggest that 
there is a significant discrepancy in reported incidence. 
Thus, Webster cites that the phlebitis rate ranges from 
2.3% - 67%(3).
No generally accepted classification of predisposing 
factors for phlebitis exists. A large number of risk factors 
have been identified in various studies, and they can 
be classified as those relating to: patients, cannula, 
administered therapy, and other factors(1,4).
Most common patient-related risk factors include: 
age, gender, and associated diseases. Incidence 
of phlebitis increases with age; with most studies 
showing that obvious signs of phlebitis were present 
in approximately 50% of patients over the age of 
60(5). Although most studies suggest that phlebitis is 
more prevalent in women, there is still no satisfactory 
explanation for such findings(6-7). Furthermore, conditions 
that impair circulation(e.g., peripheral vascular disease, 
and smoking status), and conditions that cause lack 
of sensation (peripheral neuropathy) increase the 
risk of phlebitis. Other associated diseases, especially 
diabetes, can contribute significantly to the occurrence 
of phlebitis(5).
Physicochemical properties of the peripheral 
venous cannula (PVC) material and its size affect the 
development of phlebitis(3).The results obtained in the 
study conducted by Maki and Ringer(8) indicate that the 
incidence of phlebitis following the use of PTFE (Teflon®) 
cannulas is 30 % higher than following the use of 
Vialone (Vialone®) cannulas. Choosing an inadequate 
cannula diameter can increase the rate of phlebitis, and 
the risk rises with increasing diameter(5-6). A smaller 
diameter PVC that accommodates the patient’s veins and 
prescribed therapy minimizes the risk of phlebitis(9-10). 
Proper stabilization and securing of the insertion 
site can significantly reduce the risk of phlebitis, and 
other phlebitis-related complications(11-13). The risk of 
mechanical phlebitis is significantly lower with a proper 
primary (proximal) and secondary (distal) stabilization 
of the cannula(14). Most current standards and best-
practice guidance indicate that PVC replacement should 
be considered every 72-96 hours(9,15). Results of the 
previous studies show that the incidence of phlebitis 
increases three or four days after PVC insertion(8), or 
when a cannula is inserted in an antecubital vein(5,16) or 
wrist region(8).
There is a significant risk of the development 
of chemical phlebitis if the pH and osmolality in the 
medications and solutions are different in relation to 
their values in the blood(17). Hypertonic solutions with 
an osmolality greater than 450mOsm/l and those with 
a pH of less than 5.0 are associated with the frequent 
occurrence of phlebitis(4-5,18). The use of antibacterial 
medications, primarily from the beta-lactam group, may 
also increase the risk of chemical phlebitis(18).
One of the major risks for phlebitis incidence is 
related to the placement and maintenance of a PVC 
by insufficiently trained staff and staff with less work 
experience(19).
Intravenous therapy is an integral part of professional 
nursing practice in all healthcare institutions in Serbia 
and Croatia. A nurse should possess required knowledge 
and skills for setting up and maintaining IV equipment, 
the patient’s venous system, as well as knowledge of 
the physicochemical characteristics of the administered 
medications. Given that intravenous therapy is often 
accompanied by complications, phlebitis being among the 
most common, nurses have a responsibility to minimize 
this incidence, at the same time ensuring that patients 
receive treatment in an appropriate and timely manner.
Nurses’ knowledge and early recognition of risk 
factors for the development of phlebitis can reduce 
complications. This improves the quality of care, patient 
safety, patient satisfaction ratings, and at the same time 
reduces length of hospital stay and the overall cost of 
health care.
Therefore, the aim of this study was to assess the 
nurses’ perception of risk factors relating to the patient, 
cannula and administered therapy, with a special 
focus on the perception of phlebitis potentials of some 
medications and solutions.
Method
The study was conducted in three health care 
institutions in Serbia and Croatia (Novi Sad, Niš 
and Osijek, respectively), using a cross-sectional, 
questionnaire method, in September of 2012.
A modified questionnaire of Lanbeck et al.(20) was 
used as the survey instrument. As it was not copyrighted, 
permission was not necessary in order to use and modify 
some of their items for our study. Modification included 
the expansion of the questionnaire with the questions 
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related to risk factors, such as the choice of antiseptic 
agents, syringe cleaning agents and use of infusion 
pumps, as well as revision of the questions related to the 
material of the cannula and its insertion site. To assess 
the reliability of the questionnaire, a pilot test–retest 
study with a three-week interval check was performed. 
A Cohen’s k > 0.60 was determined to be the good level 
of item reliability.
The questionnaire contained three sections and an 
introductory paragraph which provided the definition of 
phlebitis.The first section was used to collect general 
data (gender, age, and job data). The second section 
contained 17 close-ended questions regarding the risk 
factors for phlebitis and one open-ended question: 
“Do you know of any other risk factor for phlebitis not 
specified?” If the answer was “yes”, respondents were 
asked to state the other risk factor. This section of the 
questionnaire contained another two questions to which 
the nurses should respond – whether they considered 
the occurrence of phlebitis as a great, moderate or 
trivial problem, and if the occurrence of phlebitis 
indicated the quality of care provided. In the third 
section of the questionnaire, nurses ranked medications 
(antibiotics and other medications) and solutions, 
which are currently used in both countries, according 
to their impact on the development of phlebitis. Generic 
medication names were listed first, followed by the brand 
names in brackets. The rankings ranged from 1 = very 
rarely causes phlebitis, 2 = rarely causes phlebitis, 3 = 
sometimes causes phlebitis, 4 = often causes phlebitis, 
to 5 = very often causes phlebitis, while 0= indicated 
that the nurses were not familiar with the specified 
medication or solution, or that they did not administer it 
and thus they could not evaluate its phlebitic potentials.
The study included a sample of 102 nurses working 
in the adult intensive care unit (ICU) (surgical and 
internal medicine) and anaesthesia department (AD). 
As convenience sampling was used, all nurses employed 
in the adult ICU and AD for were invited to participate 
in the study. Data collection in each hospital lasted for 
three weeks. During the collection period, questionnaires 
were collected personally by the researchers, and 
nurses returned them in the sealed envelopes (provided 
by the researchers). A total of 120 questionnaires were 
distributed to the three hospitals, and 102 of them were 
completed, returned and used for analysis. The overall 
response rate was 85%.
The Statistical Package for the Social Sciences 
for Windows (SPSS, Inc., Chicago, IL, USA), version 
19.00, was used for descriptive and inferential analysis. 
Methods of descriptive statistics used in this study 
were: measures of central tendency (arithmetic mean) 
and measures of variability (standard deviation) for 
numerical characteristics and frequency determination 
(proportion) for attribute characteristics. The Pearson c2 
test for testing differences between groups was used as 
a method of inferential statistics. Values of p <0.05 were 
considered significant.
The implementation of this study was approved 
by the Ethics Committee of the Medical Faculty of the 
University of Novi Sad (May, 2012), and administration 
was approved by all health institutions where the study 
was conducted.
Results
Of the total number of nurses who participated in 
the study, 23 (22.5%) were male and 79 (77.5%) were 
female (Table 1).
The mean age of the nurses was 33.2 (SD=7.2) 
years of age. The youngest nurse was 20 and the 
oldest was 56 years old. Most of the nurses 63 (61.8%) 
completed secondary medical school, while 36 of them 
(35.3%) graduated from college or university, and three 
(2.9%) had a master’s degree in nursing. An almost 
equal number of nurses who participated in the study 
worked in surgical and internal medicine intensive care 
units (n = 43, 42.1% and n= 42, 41.2%, respectively), 
while others worked in the anesthesia care unit (n = 17, 
16.7% ). The mean work experience of the nurses was 
11.7 (SD= 7.8), with the span ranging from one to thirty-
five years.
Table 1 − Demographic characteristics of participants 
(n=102). Novi Sad, Niš and Osijek, Serbia and Croatia, 
2012
Demographic 
variable Category Frequency Percentage
Gender Male 23 22.5
Female 79 77.5
Education Secondary school 63 61.8
Technical College 13 12.7
3 – year bachelor’s degree 22 21.6
4 – year bachelor’s degree 1 1.0
Master’s degree 3 2.9
Work setting Surgical intensive care unit 43 42.1
Internal intensive care unit 42 41.2
Department of anaesthesia 17 16.7
Mean SD*







Rev. Latino-Am. Enfermagem 2015 July-Aug.;23(4):677-84.
The perception of the risk factors for phlebitis
Most nurses considered phlebitis a great problem 
(n = 69, 67.6%), whose prevalence indicated the quality 
of the nursing care (n = 67, 65.7%), while one-third 
considered phlebitis a moderate problem in patient 
care. Analysis of the other responses shows that nurses 
recognized some factors that may affect the reduction 
of the incidence of phlebitis such as: good venipuncture 
practice, regular and adequate documentation, and 
administering short-term infusions of medications. 
However, more than half of the nurses were unaware 
that the cannula material and diameter may affect 
the incidence of phlebitis, and did not distinguish the 
phlebitic potentials of the flushing solution on cannulas, 
such as heparin and 0.9% NaCL. 
The nurses also recognized the factors that influenced 
the development of phlebitis, such as choice of devices 
which facilitate dressing and securing of the intravenous 
cannula, and the length of time before the infusion system 
was replaced. The nurses’ perceptions were mostly divided 
in relation to the recommended time of IV medication 
administration, setting cannula in situ, and the impact of 
the choice and methods of local anesthetic administration 
on the reduction of the incidence of phlebitis.
In the nurses’ opinion, factors that could lead to 
phlebitis were: higher medication concentration and 
medications or solutions with a higher pH, as well as 
thromboembolic diseases, diabetes mellitus and venous 
insufficiency.
After analyzing nurses’ perceptions about the risk 
factors for phlebitis, we observed a difference, depending 
on the level of education (Table 2).
Table 2 −The nurses’ perception of some risk factors for 
phlebitis in relation to educational level. Novi Sad, Niš 
and Osijek, Serbia and Croatia, 2012
Offered Responses Secondary school n (%)
Technical College, 
Bachelor’s and Master 
degree n (%)
In youropinion,which cannula material reduces the risk for 
phlebitis?
Teflon® 7 (11.0) 13 (33.4)
Vialon® 11 (17.7) 12 (30.8)
I don’t know 45 (71.3) 14 (35.8)
c2 test = 13.216; p = 0.001
Do you think that the length of time before the infusion 
system is replaced influences the development of phlebitis?
Yes 27 (42.9) 29 (74.4)
No 31 (49.2) 8 (20.5)
I don’t know 5 (7.9) 2 (5.1)
c2 test = 9.818; p = 0.007
Offered Responses Secondary school n (%)
Technical College, 
Bachelor’s and Master 
degree n (%)
In your opinion, the IV cannula placed in situ (in one place):
Should stay no 
longer than 24 
hours
5 (7.9) 7 (17.9)
Should stay 
no longer than 
48hours
14 (22.2) 12 (30.8)
Should stay 
no longer than 
72hours
15 (23.8) 13 (33.4)
Should be replaced 
depending on the 
clinical indications
29 (46.1) 7 (17.9)
c2 test = 8.921; p = 0.03
Nurses with secondary education, as opposed to 
nurses with higher education, were not aware that 
the cannula’s material (c2 test = 13.216; p = 0.001) 
and the replacement time of the infusion system (c2 
test = 9.818; p = 0.007) could affect the incidence 
of phlebitis. A difference was also noted in terms of 
the time of maintaining an intravenous cannula in 
situ. A significant number of nurses with secondary 
education believed that the intravenous cannula should 
be replaced depending on clinical indications (c2 test = 
8.921; p = 0.03).
With regard to work experience, there was 
a significant difference in the nurses’ perception 
about the selection of an appropriate insertion site 
for an intravenous cannula, in order to reduce the 
incidence of phlebitis (c2 test = 29.691, p = 0.003) 
and the recommended time for the IV medication 
administration (c2 test = 16.986, p = 0.049). Nurses 
who had between six and ten years of experience made 
a better choice of veins (forearm veins), in comparison 
to colleagues with less experience who predominantly 
selected hand veins. Less experienced nurses (£ 5 
years) would administer infusion medications lasting 
more than 60 minutes.
Phlebitic potentials of some medications and 
solutions
Phlebitic potentials of antibiotics, which nurses 
administered in their everyday practice, were rated from 
2.21 to 3.12 (Table 3), other medications from 1.90 to 
2.77 (Table 4), and solutions from 1.62 to 3.39 (Table 5).
Nurses identified Vancomycin (3.12±1.26) and 
Benzylpenicillin (3.06±1.13) as antibiotics with the 
strongest phlebitic potential (Table 3).(continue...)
Table 2 - (continuation)
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Among other medications, Calcium glubionate 
(2.77±1.35); Aminophylline (2:58±1:18) and 
Amiodarone hydrochloride (2.56±1.21) were also 
identified as potentially causing phlebitis (Table 4).
Table 3− Phlebitic potentials of intravenous antibiotics. 
Novi Sad, Niš and Osijek, Serbia and Croatia, 2012
Generic Name n* Min. Max. Mean SD†
Chlarithomycin 42 1 5 2.21 1.04
Azithromycin 75 1 5 2.39 1.11
Vancomycin 94 1 5 3.12 1.26
Aciclovir 58 1 5 2.45 1.14
Ceftazidime 92 1 5 2.58 1.12
Tigecycline 71 1 5 2.83 1.06
Imipenem/cilastatin 92 1 5 2.59 1.16
Ertapenem 76 1 5 2.71 0.89
Netilmicin 71 1 5 2.55 1.03
Cefotaxime 81 1 5 2.36 1.02
Ciprofloxacin 94 1 5 2.64 1.28
Benzylpenicillin 65 1 5 3.06 1.13
Clindamycin 93 1 5 2.60 1.09
Metronidazole 96 1 5 2.39 1.23
Cefuroxime 96 1 5 2.26 1.17
Gentamicin 97 1 5 2.31 1.14
Amikacin 95 1 5 2.41 1.14
*n = Number of participants who rated the drug
†Standard deviation
Table 4 − Phlebitic potentials of intravenous medications 
other than antibiotics. Novi Sad, Niš and Osijek, Serbia 
and Croatia, 2012
Generic Name n* Min. Max. Mean SD†
Diazepam 89 1 5 2.17 1.27
Epinephrine hydrochloride 87 1 5 1.90 1.07
Aminophylline 91 1 5 2.58 1.18
Pethidine hydrochloride 54 1 4 2.24 0.97
Digoxin 86 1 5 2.16 1.13
Amiodarone hydrochloride 90 1 5 2.56 1.21
Hydrocortisone 84 1 5 2.37 1.31
Metoclopramide 90 1 5 2.01 1.02
Morphine hydrochloride 83 1 5 2.54 1.32
Heparin 86 1 5 1.93 1.15
Furosemid 89 1 5 1.87 0.97
Calcium glubionate 88 1 5 2.77 1.35
*n = Number of participants who rated the drug
†Standard deviation
According to nurses’ perception, potassium chloride 
7.4% (3.39 ± 1.32) is an intravenous fluid often causing 
phlebitis (Table 5).
Table 5 − Phlebitic potentials of intravenous fluids. Novi 
Sad, Niš and Osijek, Serbia and Croatia, 2012
Intravenous Fluid n* Min. Max. Mean SD†
Glucose 10% 90 1 4 1.74 0.91
Glucose 5% 92 1 5 1.65 0.95
Intralipid lipids 20% 71 1 5 3.11 1.37
Amino acid 15% 78 1 5 3.08 1.28
Amino acid 10% 83 1 5 3.08 1.35
Amino acid 5% 75 1 5 3.03 1.26
Amino acid - Hepatosol8% 69 1 5 2.93 1.31
Vamin aminoacids 14 g 34 1 5 2.82 1.16
Emulsion for infusion 
(Glucose, Amino acids and 
electrolytes Fat emulsion)
73 1 5 3.01 1.45
Albumin (human) 20% 88 1 5 2.30 1.19
Polygeline infusion solution 
3.5%
70 1 5 1.93 1.01
6% Hydroxyethyl Starch 
130/0.4 in 0.9% Sodium 
Chloride Injection
89 1 5 1.84 0.93
Erythrocyte concentrate 93 1 5 2.67 1.21
Fresh – frozen plasma 92 1 5 2.45 1.17
Ringer’s solution 91 1 4 1.62 0.82
Hartmann’s solution 78 1 5 1.71 1.02
Mannitol 10% 88 1 5 2.03 0.96
Mannitol 20% 90 1 5 2.24 1.10
Potassium chloride 7.4% 93 1 5 3.39 1.32
0.9% Sodium 
Chloride Solution
94 1 5 1.73 1.09
Sodium Bicarbonate 8.4% 90 1 5 2.44 1.19
*n = Number of participants who rated the fluid
†Standard deviation
Discussion
The aim of this study was to evaluate the perceptions 
of nurses about risk factors for phlebitis and the phlebitic 
potential of some medications. It was conducted in 
the health care institutions of Serbia and Croatia, in 
which the educational and professional competence of 
nurses were almost identical prior to Croatian entry 
to the European Union. Both countries were members 
of the former Socialist Federal Republic of Yugoslavia 
and they both had (and Serbia still does) a traditional 
form of nurse education at the secondary school (four-
year education for nurses after eight years of general 
education), with the possibility of continuing their 
education at a higher level, and then obtaining the title 
of master’s in nursing. It is therefore not surprising that 
61.8% of nurses with secondary education participated 
in the study. However, the majority of nurses identified 
phlebitis as a major problem and its incidence as the 
indicator of the quality of nursing care.
Comparing the current standards of infusion 
therapy(9-10) and the nurses’ knowledge about risk factors 
for phlebitis with our findings, we observed a large gap 
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between the two. Namely, although some studies have 
confirmed that the cannula material influences the 
development of phlebitis(8), nurses in our study did not 
recognize this as a predisposing factor. The reason for 
this misperception could be interpreted by the increased 
availability of Teflon® cannulas. Despite the wide variety 
of types of intravenous cannula in the European market, 
the main discriminator in selecting them is their price(21). 
Therefore, institution management often opts for Teflon® 
cannula with a more favourable price, as they do in 
Serbia and Croatia.
For a successful and safe use of intravenous therapy 
and a reduction of complication rates, it is important 
to respect the golden rule: “The catheter selected shall 
be of the smallest gauge and length, with the fewest 
number of lumens, and shall be the least invasive device 
needed to accommodate and manage the prescribed 
therapy”(10). Taking into account that 41.2% of nurses 
chose the largest offered diameter cannula (18G) as a 
dimension that reduces the risk of phlebitis, while only 
21.6% opted for the lowest offered diameter (22G), it 
could be concluded that the golden rule is not followed 
by all nurses involved in the study. Since the study 
was conducted in the intensive care units, we assume 
that nurses based this decision on their perception 
that rapid volume restoration, which is often needed 
by the critically ill, requires a larger cannula diameter, 
regardless of the possible risk of adverse complications.
Flushing and locking are important procedures that 
influence both the effectiveness and safety of therapy 
administered through an intravenous cannula(9-10). 
Therefore, it is important to select the appropriate 
solution. Comparing the effectiveness and safety of 
0.9% sodium chloride solution versus heparin saline 
solution as flushing and locking solutions for peripheral 
intravenous access devices in a prospective controlled 
trial, Wang et. al.,(22) concluded that both agents are 
equally effective and safe. This was confirmed in our 
study, where a difference in the phlebitic effect of these 
two solutions was not perceived by nurses, either. 
In contrast, Bertolino et. al.(23) found that the rate of 
cannula-related phlebitis/occlusions was significantly 
lower in the group of patients who used heparin as a 
flushing solution. At the same time, Bertolino et. al.(23) 
recommend that cost/ benefit analyses should be done 
before making the final decision on the choice of agents.
In terms of retaining intravenous cannula in situ, 
nurses’ perceptions were greatly divided. Therefore, 
for successful intravenous medicine management and 
reduction in associated complications, it is essential to 
address the issue of the time of cannula replacement. 
Taking into account that globally, a large number of 
patients require intravenous cannulation, clinically 
indicated versus routine replacement in 72 – 96 hours 
would have a positive effect on health care costs 
worldwide(24). Routine replacement of the cannula was 
and still is the source of an overwhelming expenditure 
and burden on patients and nurses.
There is still another dilemma to be resolved 
for successful intravenous medicine management. 
Namely, the nurses in clinical practice are faced with 
a variety of recommendations regarding site selection. 
Recommendations of the RCN(9) and INS(10) suggest 
that initial cannulation should be in the veins of the 
upper extremity in the distal areas, while subsequent 
cannulation should be made proximal to the previous 
one. In our study, nurses’ perception that the hand 
veins have a lower risk for phlebitis areprobably due to 
the influence of previous CDC recommendations for the 
Prevention of Intravascular Catheter-Related Infections.
In analyzing the nurses’ perception of phlebitic 
effects of some antibiotics, it was expected that they 
would recognize Vancomycin and Benzylpenicillin as 
potentially potent medications. Namely, with its pH of 
2.5-4.5, Vancomycin is a very vessel-irritating antibiotic; 
whereas Benzylpenicillin, classified as a beta-lactam 
antibiotic, has an irritating effect. Cefuroxime, in our 
study, was not significantly associated with a higher risk, 
although it is classified as a beta-lactams. To reduce 
the rate of phlebitis and avoid a mistake in medication 
administration known as “failure to check for phlebitis”, 
medications with an extremely acidic pH of 2.5 - 3.5 
should be diluted with a volume of 200 - 500ml(18).
Other potent medications identified by nurses 
were Calcium glubionate, Aminophylline and 
Amiodaronehydrochloride. Calcium glubionate cause 
injection site irritation, while Aminophylline (pH 8.8-
10) and Amiodarone hydrochloride (pH 3-5) are 
medications which may be related to the incidence 
of phlebitis, due to their extreme pH. For example, 
in the study of Norton et. al.(25), Amiodarone 
hydrochloride-induced phlebitis occurred in 40% of 
patients. Potassium chloride 7.4%, as well as the other 
hyperosmolar solutions, but also acidic solutions such 
as parenteral nutrition solutions and glucose ≥ 10%, 
are known to be risk factors for phlebitis. This was well 
known to nurses in our study.
A periodic check of nurses’ perceptions about 
risk factors for the development of phlebitis, using 
the questionnaire that was administered in this study, 
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can help nurse managers to determine in which part 
of the process of administering intravenous therapy 
(preparation, administration or monitoring) the nurse 
should receive education or training courses. Therefore, 
results from this study are a good basis for the design of 
educational activities. In addition, this questionnaire can 
be applied to assess the learning outcomes before and 
after these courses. Improving knowledge regarding risk 
factors and altering nurses’ practices could significantly 
reduce the risk for phlebitis. In addition to being 
valuable for further research, the results of this study 
can become the basis for improving the concept of 
nursing care quality and patient safety.
Limitations
Results from this study add information to the body 
of knowledge on nurses’ perceptions about risk factors 
for phlebitis. However, some limitations should be noted. 
The use of a convenience sample, drawn only from the 
intensive care unit and anesthesiology department from 
two hospitals in Serbia, and one from Croatia, limits the 
generalizability of the findings. Future studies should 
recruit larger random samples of nurses from different 
settings and across a broader geographical area.
Conclusion
Phlebitis as a common local complication of peripheral 
intravenous therapy was perceived as a significant 
problem in clinical practice by nurses who participated 
in this study. However, some risk factors related to its 
occurrence, especially risk factors associated with the 
cannula, were not fully perceived. The majority of nurses 
did not identify the effects of the cannula material, its 
diameter, the time before cannula were replaced, and 
solutions used to flush the cannula as potential risk 
factors. However, risk factors related to the patient and 
administered therapy were well known. Namely, nurses 
were aware of the fact that some underlying diseases 
increase the incidence of phlebitis, as well as the phlebitic 
effects of certain medications and solvents, such as 
Vancomycin, Benzylpenicillin, Calcium Glubionate, 
Aminophylline and Amiodarone Hydrochloride.
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